Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk

International Journal of Cancer

Volumn 118, Issue 10, 2006, Pages 2505-2508

  Frank, Bernd ^a   Hemminki, Kari ^a,b   Meindl, Alfons ^c   Wappenschmidt, Barbara ^d,e   Klaes, Rüdiger ^f   Schmutzler, Rita K ^d,e   Untch, Michael ^g   Bugert, Peter ^f   Bartram, Claus R ^f   Burwinkel, Barbara ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

Author keywords

ARLTS1; Familial breast cancer; Polymorphism; Risk; Tumor suppressor gene

Indexed keywords

ADP RIBOSYLATION FACTOR LIKE TUMOR SUPPRESSOR GENE 1; ARGININE; CYSTEINE; GENE PRODUCT; LEUCINE; PROLINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARLTS1 GENE; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ADP-RIBOSYLATION FACTORS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; FUNCTIONAL LATERALITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; PEDIGREE; RISK FACTORS; VARIATION (GENETICS);

EID: 33646431149     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21687     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Parkin DM. Epidemiology of cancer: global patterns and trends. Toxicol Lett 1998;102/103:227-34.
3. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden. Denmark, and Finland. N Engl J Med 2000;343:78-85.
5. Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000;26:411-4.
6. Hemminki K, Granstrom C. Familial breast cancer: scope for more susceptibility genes? Breast Cancer Res Treat 2003;82:17-22.
7. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999;1:14-7.
8. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, Shaapveld M, de Vries EG. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 2002;39:225-42.
9. Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005;352:1667-76.
10. Moss J, Vaughan M. Molecules in the ARF orbit. J Biol Chem 1998;273:21431-4.
11. Forsti A, Luo L, Vorechovsky I, Soderberg M, Lichtenstein P, Hemminki K. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer. Carcinogenesis 2001;22:27-33.
12. Forsti A, Louhelainen J, Soderberg M, Wijkstrom H, Hemminki K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur J Cancer 2001;37:1372-80.
13. Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R. Evidence of chromosome regions and gene involvement in inflammatory breast cancer. Int J Cancer 2002;102:618-22.
14. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, Croce CM. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 1996;88:3109-15.
15. Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 2001;61:6640-8.
16. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-9.
17. Yin Z, Spitz MR, Babaian RJ, Strom SS, Troncoso P, Kagan J. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 1999;18:7576-83.
18. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A, Sabe H. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci USA 2004;101:6647-52.
19. Frank B, Klaes R, Burwinkel B. Familial cancer and ARLTS1. N Engl J Med 2005;353:313-4.
20. Meindl A. German consortium for hereditary breast and ovarian cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 2002;97:472-80.
21. Frank B, Hemminki K, Wirtenberger M, Bermejo JL, Bugert P, Klaes R, Schmutzler RK, Wappenschmidt B, Bartram CR, Burwinkel B. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. Carcinogenesis 2005;26:643-7.
22. Maquat LE. Nonsense-mediated mRNA decay in mammals. J Cell Sci 2005;118:1773-6.
23. Mashima Y, Murakami A, Weleber RG, Kennaway NG, Clarke L, Shiono T, Inana G. Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet 1992;51:81-91.
24. Reumers J, Schymkowitz J, Ferkinghoff-Borg J, Stricher F, Serrano L, Rousseau F. SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs. Nucleic Acids Res 2005;33:D527-32.
25. Sunyaev S, Ramensky V, Koch I, Lathe W, III, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001;10:591-7.
26. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894-900.
27. Abudugupur A, Mitsui K, Yokota S, Tsurugi K. An ARL1 mutation affected autophagic cell death in yeast, causing a defect in central vacuole formation. Cell Death Differ 2002;9:158-68.
28. Imyanitov EN, Hanson KP. Molecular pathogenesis of bilateral breast cancer. Cancer Lett 2003;191:1-7.
29. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, Ponder BA, Meuth M, Bhattacharyya NP, Cox A. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004;96:1866-9.
30. Frank B, Bermejo JL, Hemminki K, Klaes R, Bugert P, Wappenschmidt B, Schmutzler RK, Burwinkel B. Re: association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2005;97:1012.
31. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B. Association of the CASP10 V410I variant with reduced familial breast cancer risk. Carcinogenesis-2005; [epub ahead of print Oct. 26].